Cargando...
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor–positive cells
Unintentional transduction of B-cell acute lymphoblastic leukemia blasts during CART19 manufacturing can lead to CAR19(+) leukemic cells (CARB19) that are resistant to CART19 killing. We developed an anti-CAR19 idiotype chimeric antigen receptor (αCAR19) to specifically recognize CAR19(+) cells. αCA...
Guardado en:
| Publicado en: | Blood |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7019191/ https://ncbi.nlm.nih.gov/pubmed/31703119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019001859 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|